These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23898085)

  • 1. c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.
    Ang CS; Sun MY; Huitzil-Melendez DF; Chou JF; Capanu M; Jarnagin W; Fong Y; Dematteo RP; D'Angelica M; Allen P; Chen CT; O'Reilly EM; Weiser MR; Abou-Alfa GK
    Anticancer Res; 2013 Aug; 33(8):3241-5. PubMed ID: 23898085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
    Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
    Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling.
    Yu J; Xia X; Dong Y; Gong Z; Li G; Chen GG; Lai PBS
    Theranostics; 2021; 11(5):2123-2136. PubMed ID: 33500715
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway.
    Liu Y; Tan J; Ou S; Chen J; Chen L
    Invest New Drugs; 2020 Feb; 38(1):60-69. PubMed ID: 30929159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.
    Ogunwobi OO; Puszyk W; Dong HJ; Liu C
    PLoS One; 2013; 8(5):e63765. PubMed ID: 23723997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells.
    Yang H; Magilnick N; Noureddin M; Mato JM; Lu SC
    J Cell Physiol; 2007 Mar; 210(3):766-73. PubMed ID: 17154373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
    Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
    Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.
    Yao Y; Dou C; Lu Z; Zheng X; Liu Q
    Cell Physiol Biochem; 2015; 35(3):983-96. PubMed ID: 25660117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
    Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
    Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Firtina Karagonlar Z; Koc D; Iscan E; Erdal E; Atabey N
    Cancer Sci; 2016 Apr; 107(4):407-16. PubMed ID: 26790028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.
    Bu WJ; Fang Z; Li WL; Wang X; Dong MJ; Tao QY; Zhang L; Xu YQ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10452-10461. PubMed ID: 33155201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
    Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
    Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
    Tan S; Li R; Ding K; Lobie PE; Zhu T
    FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
    Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
    Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
    Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.